Medical device technology assessment

A university research team had worked for a number of years on the development of a novel interventional cardiology device. Recent progress had been made with pre-clinical testing on pigs, as well as...
Learn More

Supporting due diligence on regulatory affairs

Challenge: A clinical stage biopharmaceutical specialist needed support with its regulatory due diligence activities for products in the respiratory field.
Learn More

Opportunity analysis - blood products

A life science venture capital fund was contemplating investing in advanced plasma product opportunities being developed by a biopharmaceutical company.  Alacrita was commissioned to provide a...
Learn More

GMP facility - feasibility study for biologics production

Drawing on expertise from its regulatory, gene therapy and manufacturing consultants, Alacrita conducted feasibility study and formulated a business case for a new GMP facility for production of...
Learn More

Valuation and Deal Support

Oncology company with a preclinical project seeking finance and potential acquisition For a virtual life science company, Alacrita helped establish a valuation trajectory for one of their products,...
Learn More

Clinical strategy, medical oversight and clinical due diligence

Alacrita's consulting team supports a number of pharmaceutical & biotech companies with medical and clinical strategy. We have particular depth in oncology, but also have expertise in infectious...
Learn More

Observer on BoD for private equity investor

On behalf of a private equity (PE) investor, an Alacrita partner was retained as an observer on the board of a regenerative medicine/advanced wound healing company where he contributed to BoD...
Learn More

Life Science Technology Scouting

Life science scouting Since 2013, Rob Johnson, based in Boston, MA, has been engaged by a well-capitalized Swiss pharma company to scout and identify early stage in-licensing opportunities from the...
Learn More

Due diligence on a diagnostics investment opportunity

Challenge: A major European venture capital investor needed help to review the business plan and competitive positioning of a novel point-of-care diagnostics company. The company was developing a...
Learn More

Ex-US diagnostics business development strategy

Alacrita's diagnostics consultants were tasked with developing an ex-US business development strategy and identifying sources of non-dilutive finance for a well-funded venture capital funded...
Learn More

Cancer immunotherapy consulting

Alacrita Consulting's founders worked together for over 10 years at Onyvax, a London-based cancer immunotherapy company backed by SR One. We have conducted a number of consulting projects in the...
Learn More

Strategy for biomarker identification technology

Alacrita’s antibody consultants were engaged to help a start-up company that had developed a suite of proprietary antibody technologies to identify accessible cell surface proteins for discovery of...
Learn More
Content not found